The pharmacovigilance toolkit

被引：0

作者：

Shankar, P. Ravi ^{[1
]}

机构：

[1] Xavier Univ, Sch Med, Dept Pharmacol, 23, Oranjestad, Aruba

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：307 / 308

页数：2

共 50 条

[31] TRANSNATIONAL PHARMACOVIGILANCE
CHOO, V
LANCET, 1993, 342 (8874): : 797 - 798
[32] The Importance Of Pharmacovigilance
Shankar, P. R.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2008, 2 (06) : 1246 - 1247
[33] PHARMACOVIGILANCE, A NECESSITY
IMBS, JL
JOURNAL DE MEDECINE DE STRASBOURG, 1982, 13 (08): : 601 - 601
[34] PHARMACOVIGILANCE IN GERMANY
THURMANN, P
HARDER, S
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (03) : 159 - 159
[35] Pharmacovigilance in Perspective
Ronald H. B. Meyboom
Antoine C. G. Egberts
Frank W. J. Gribnau
Yechiel A. Hekster
Drug Safety, 1999, 21 : 429 - 447
[36] PHARMACOVIGILANCE GUIDELINES
LEWIS, S
LANCET, 1994, 343 (8896): : 535 - 535
[37] Transparency in pharmacovigilance
van Grootheest, AC
Kabel, JS
van Puijenbroek, E
DRUG SAFETY, 2005, 28 (10) : 936 - 936
[38] Bismuth and pharmacovigilance
Trenque, Thierry
THERAPIE, 2021, 76 (05): : 383 - 384
[39] Pharmacovigilance in Poland
Czarnecki, A
Maciejczyk, A
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1997, 6 (04) : 277 - 281
[40] Pharmacovigilance in oncology
Paolo Baldo
Giulia Fornasier
Laura Ciolfi
Ivana Sartor
Sara Francescon
International Journal of Clinical Pharmacy, 2018, 40 : 832 - 841